Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Post by happyretirementon Feb 24, 2017 10:28am
265 Views
Post# 25888640

Interesting Decision???

Interesting Decision???Does the CMA not group all companies involved with a specific drug together in their investigation, or have they changed that method since Feb.16th or more recently the Pfizer case???

The CMA is also investigating the Company's International segment with respect to an agreement with a third party and certain subsidiaries of the Company relating to hydrocortisone tablets in the UK. The investigation also concerns a matter that pre-dates Concordia's ownership of the International segment.

The Company is fully cooperating with the investigation and the CMA has not reached a view as to whether or not it may proceed with its investigation to any finding of a competition law violation.

Contains Parliamentary information licensed under the Open Parliament Licence v3.0.

https://www.gov.uk/government/news/pharmaceutical-company-accused-of-overcharging-nhs

https://www.gov.uk/government/news/cma-fines-pharma-companies-45-million
<< Previous
Bullboard Posts
Next >>